Skip to main content

Table 1 Breast tumor clinicopathological characteristics

From: Dysregulated miR-183 inhibits migration in breast cancer cells

Breast Cancer Clinicopathological Characteristics Number of Patients
N = 70
Median Patient Age yrs (IQR) 52 (48-64)
Median Tumor Size mm (IQR) 25 (20-35)
Histologic Subtype  
Invasive Ductal 59
Invasive Lobular 6
Colloid/Mucinous 2
Tubular 2
Papillary 1
Intrinsic Subtype  
Luminal A (ER/PR+, HER2/neu-) 38
Luminal B (ER/PR+, HER2/neu+) 7
HER2 Overexpressing (ER-, PR-, HER2/neu+) 10
Triple-Negative (ER-,PR-,HER2/neu-) 9
Missing data 6
Grade  
1 13
2 17
3 38
Missing data 2
Nodal Status  
Node Negative 46
N1 8
N2 11
N3 5
ER Status  
-ER Positive 41
-ER Negative 29
PR Status  
PR Positive 41
PR Negative 27
Missing data 2
HER2/ neu Status  
HER2 Positive 18
HER2 Negative 47
Missing data 5
UICC Stage  
Stage 1 19
Stage 2a 28
Stage 2b 4
Stage 3a 9
Stage 3b 3
Stage 3c 5
Stage 4 2